Stellate Ganglion Block to Reduce Hot Flushes (NCT03756272) | Clinical Trial Compass
CompletedNot Applicable
Stellate Ganglion Block to Reduce Hot Flushes
Netherlands76 participantsStarted 2017-09-01
Plain-language summary
To assess the short-term efficacy of stellate ganglion block on hot flush reduction versus sham procedure
Who can participate
Age range30 Years – 70 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female
* Age: 30-70 years
* Mean daily flush frequency of 10 or more and a hot flush score of 15 or more
* Absence of any non-menopausal cause of flushing
* Post-menopause amenorrhea for more than 1 year in healthy postmenopausal women
* In case of breast cancer or ovariectomy induced menopause: ovariectomy for \> 6 months. Adjuvant therapy with estrogen-receptor blocker or an aromatase inhibitor.
Exclusion Criteria:
* Use of medication that affects flushing:oestrogens, progestogens, clonidine, naloxone, paroxetine, fluoxetine, venlafaxine, gabapentin, luteĂ¯niserend hormone releasing hormones receptor antagonist
* Receiving chemotherapy of radiotherapy
* Active psychiatric disease
* Active concurrent disease
* Allergic reactions against local anesthetics of the 'amide' type or contrast media.